Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong · Delayed Price · Currency is HKD 6.43
-0.31 (-4.60%)
Oct 2, 2026, 4:08 PM HKT
Medlive Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 645.32 | 642.16 | 558.46 | 412 | 314.05 | 284.44 | |
Revenue Growth | 2.91% | 14.99% | 35.55% | 31.19% | 10.41% | 33.21% |
Cost of Revenue | 249.7 | 256.72 | 231.23 | 160.67 | 101.31 | 83.71 |
Gross Profit | 395.63 | 385.44 | 327.22 | 251.34 | 212.74 | 200.73 |
Selling, General & Admin | 207.76 | 217.04 | 208.99 | 177.26 | 151.34 | 127.67 |
Other Operating Expenses | -0.85 | 1.05 | 0.79 | 9.07 | 1.58 | 11.46 |
Operating Expenses | 206.91 | 218.08 | 209.78 | 186.33 | 152.92 | 139.13 |
Operating Income | 188.71 | 167.36 | 117.44 | 65.01 | 59.82 | 61.6 |
Interest Expense | -0.48 | -0.55 | -0.79 | -0.36 | -0.53 | -0.54 |
Interest & Investment Income | 170.97 | 180.11 | 206.26 | 184.67 | 66.96 | 7.84 |
Earnings From Equity Investments | - | - | - | 0.01 | 0.01 | -0 |
Currency Exchange Gain (Loss) | - | - | 3.24 | - | - | - |
Other Non Operating Income (Expenses) | 3.93 | 4.58 | 5.19 | 3.81 | 8.78 | 1.02 |
EBT Excluding Unusual Items | 363.12 | 351.49 | 331.34 | 253.13 | 135.04 | 69.93 |
Other Unusual Items | 8.8 | 8.8 | 9.13 | - | - | - |
Pretax Income | 371.92 | 360.29 | 340.47 | 253.13 | 135.04 | 69.93 |
Income Tax Expense | 16.63 | 12.4 | 10.17 | 1.37 | 8.62 | 24.68 |
Earnings From Continuing Operations | 355.29 | 347.89 | 330.3 | 251.76 | 126.42 | 45.25 |
Minority Interest in Earnings | -14.75 | -13.55 | -15.16 | -9.46 | -9.1 | -4.63 |
Net Income | 340.54 | 334.34 | 315.15 | 242.3 | 117.32 | 40.62 |
Net Income to Common | 340.54 | 334.34 | 315.15 | 242.3 | 117.32 | 40.62 |
Net Income Growth | 5.18% | 6.09% | 30.06% | 106.53% | 188.85% | -52.33% |
Shares Outstanding (Basic) | 736 | 733 | 729 | 722 | 714 | 616 |
Shares Outstanding (Diluted) | 736 | 737 | 736 | 735 | 737 | 636 |
Shares Change | -0.06% | 0.07% | 0.23% | -0.26% | 15.84% | 18.82% |
EPS (Basic) | 0.46 | 0.46 | 0.43 | 0.34 | 0.16 | 0.07 |
EPS (Diluted) | 0.46 | 0.45 | 0.43 | 0.33 | 0.16 | 0.06 |
EPS Growth | 5.26% | 6.03% | 29.74% | 107.09% | 149.30% | -59.86% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 133.91 | 123.07 | 96.36 | 101.12 | 75.84 | 42.47 |
Free Cash Flow Per Share | 0.18 | 0.17 | 0.13 | 0.14 | 0.10 | 0.07 |
Dividend Per Share | 0.274 | 0.260 | 0.257 | 0.232 | 0.065 | 0.017 |
Dividend Growth | 8.37% | 1.17% | 11.06% | 253.98% | 284.71% | - |
Gross Margin | 61.31% | 60.02% | 58.59% | 61.00% | 67.74% | 70.57% |
Operating Margin | 29.24% | 26.06% | 21.03% | 15.78% | 19.05% | 21.66% |
Profit Margin | 52.77% | 52.06% | 56.43% | 58.81% | 37.36% | 14.28% |
Free Cash Flow Margin | 20.75% | 19.16% | 17.25% | 24.54% | 24.15% | 14.93% |
EBITDA | 202.95 | 174.99 | 120.66 | 68.92 | 61.72 | 63.73 |
EBITDA Margin | 31.45% | 27.25% | 21.61% | 16.73% | 19.65% | 22.41% |
D&A For EBITDA | 14.24 | 7.63 | 3.22 | 3.91 | 1.9 | 2.13 |
EBIT | 188.71 | 167.36 | 117.44 | 65.01 | 59.82 | 61.6 |
EBIT Margin | 29.24% | 26.06% | 21.03% | 15.78% | 19.05% | 21.66% |
Effective Tax Rate | 4.47% | 3.44% | 2.99% | 0.54% | 6.38% | 35.30% |